Sodium Lactate
Head Trauma
Institut d'Anesthesiologie des Alpes MaritimesSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Head Trauma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid Hadassah Medical Organization | Phase 4 | BB |
Oxygen Jay C. Buckey Jr. | Phase 4 | BB |
SUFENTANYL Pierre-Julien CUNGI | Phase 2 | CCC |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Pierre-Julien CUNGI | Phase 2 | CCC |
Rosuvastatin Universidad Autonoma de San Luis Potosí | Phase 1/2 | CCC |
NEPENTHE Dalhousie University | Phase 1/2 | CCC |
MANNITOL Massachusetts General Hospital | Phase 1/2 | CCC |
RED BLOOD CELLS ThermoFisher Scientific Brahms Biomarkers France | N/A | D |
Same molecule, other indications
Sodium Lactate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →